NICHOLAS M LYTLE
Allopathic & Osteopathic Physicians|Internal Medicine|Rheumatology WEST COLUMBIA, SC NPI 1588050652
Browse related groups: Allopathic & Osteopathic Physicians|Internal Medicine|Rheumatology SC Amgen Inc. All categories
General Payments — all program years on this page
$5,080.89
- Category: General Payments
- Program years: PY2019–2024
- Record count: 176
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,836.74 across 73 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,836.74 | 73 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $316.83 | 14 |
| Octapharma USA, Inc. | $265.48 | 2 |
| ABBVIE INC. | $167.04 | 6 |
| Janssen Biotech, Inc. | $103.55 | 4 |
| Lilly USA, LLC | $102.91 | 5 |
| Acerta Pharma LLC | $96.41 | 5 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $77.04 | 3 |
| Alexion Pharmaceuticals, Inc. | $71.66 | 4 |
| Aurinia Pharma U.S., Inc. | $70.59 | 3 |
| UCB, Inc. | $66.46 | 3 |
| ANI Pharmaceuticals, Inc. | $58.52 | 2 |
| Organon LLC | $55.74 | 2 |
| SOBI, INC | $48.14 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $44.28 | 3 |
| PFIZER INC. | $44.18 | 3 |
| GENZYME CORPORATION | $43.97 | 2 |
| Genentech USA, Inc. | $38.22 | 2 |
| GlaxoSmithKline, LLC. | $29.17 | 1 |
| Fresenius Kabi USA, LLC | $26.01 | 1 |
| Kiniksa Pharmaceuticals International, plc | $22.86 | 1 |
| Sandoz Inc. | $20.04 | 1 |
| SCILEX PHARMACEUTICALS INC. | $18.92 | 1 |
| Celgene Corporation | $18.28 | 1 |
| Almatica Pharma Inc. | $16.55 | 1 |
| Azurity Pharmaceuticals, Inc. | $13.89 | 1 |
By program year
Records — PY2024 (73)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.